Efficacy and Safety of Camrelizumab Plus Apatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR or ALK Genetic Aberration.
Translational lung cancer research（2022）
Key words
Camrelizumab,Apatinib,PD-L1 expression,immunotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined